Amgen (AMGN) EBIT Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
80.35% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
2.93% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
6.88% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-411.15% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
126.32% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
15.60% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-0.98% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-193.55% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
126.32% |
| Dec 31, 2025 |
17.70% |
| Sep 30, 2025 |
23.40% |
| Jun 30, 2025 |
39.13% |
| Mar 31, 2025 |
18.87% |
| Dec 31, 2024 |
81.83% |
| Sep 30, 2024 |
1.29% |
| Jun 30, 2024 |
-28.87% |
| Mar 31, 2024 |
-48.41% |
| Dec 31, 2023 |
-43.00% |
| Sep 30, 2023 |
-24.02% |
| Jun 30, 2023 |
23.35% |
| Mar 31, 2023 |
-23.16% |
| Dec 31, 2022 |
-3.21% |
| Sep 30, 2022 |
11.86% |
| Jun 30, 2022 |
162.80% |
| Mar 31, 2022 |
17.43% |
| Dec 31, 2021 |
14.74% |
| Sep 30, 2021 |
-3.06% |
| Jun 30, 2021 |
-64.36% |
| Mar 31, 2021 |
-9.60% |
| Dec 31, 2020 |
-1.95% |
| Sep 30, 2020 |
-0.93% |
| Jun 30, 2020 |
-13.26% |
| Mar 31, 2020 |
-4.73% |
| Dec 31, 2019 |
-14.02% |
| Sep 30, 2019 |
6.59% |
| Jun 30, 2019 |
-5.44% |
| Mar 31, 2019 |
-9.32% |
| Dec 31, 2018 |
6.10% |
| Sep 30, 2018 |
-4.76% |
| Jun 30, 2018 |
4.97% |
| Mar 31, 2018 |
5.21% |
| Dec 31, 2017 |
-9.66% |
| Sep 30, 2017 |
-3.48% |
| Jun 30, 2017 |
13.36% |
| Mar 31, 2017 |
7.87% |
| Dec 31, 2016 |
22.23% |
| Sep 30, 2016 |
8.04% |
| Jun 30, 2016 |
14.64% |
| Mar 31, 2016 |
18.79% |
| Dec 31, 2015 |
39.34% |
| Sep 30, 2015 |
59.55% |
| Jun 30, 2015 |
9.15% |
| Mar 31, 2015 |
48.24% |
| Dec 31, 2014 |
22.91% |
| Sep 30, 2014 |
-13.15% |
| Jun 30, 2014 |
22.71% |
| Mar 31, 2014 |
-5.41% |
| Dec 31, 2013 |
9.10% |
| Sep 30, 2013 |
18.62% |
| Jun 30, 2013 |
-2.45% |
| Mar 31, 2013 |
-2.37% |
| Dec 31, 2012 |
-6.37% |
| Sep 30, 2012 |
171.05% |
| Jun 30, 2012 |
19.29% |
| Mar 31, 2012 |
14.23% |
| Dec 31, 2011 |
8.80% |
| Sep 30, 2011 |
-64.50% |
| Jun 30, 2011 |
-12.20% |
| Mar 31, 2011 |
-12.69% |
| Dec 31, 2010 |
-4.90% |
| Sep 30, 2010 |
-7.85% |
| Jun 30, 2010 |
4.12% |
| Mar 31, 2010 |
12.11% |
